Factors Affecting Acceptance of Participating in Clinical Trials of New Drugs: A National Cross‐Sectional Study
Shujie Dong, Mengmeng Liu, Yuanyuan Zhang, Jinzi Zhang, Qin Han, Xiaohan Chen, Yibo Wu, Wai‐kit Ming · 2026
Read Factors Affecting Acceptance of Participating in Clinical Trials of New Drugs: A National Cross‐Sectional Study by Shujie Dong, Mengmeng Liu, Yuanyuan Zhang, Jinzi Zhang, Qin Han, Xiaohan Chen, Yibo Wu, Wai‐kit Ming (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13613238.txt.
Description
Shujie Dong and colleagues report a two thousand twenty-six national survey in China on willingness to join trials of new drugs. Trials are essential for developing treatments and can give patients early access. Public acceptance, though, looked low and uneven.
Nearly twenty thousand valid questionnaires were collected over one summer. Average willingness scored below the halfway mark on a hundred-point scale. Rural residents, married people, and older respondents were more accepting. Having cancer or a rare disease also raised willingness. The findings help trial designers understand who says yes, and where trust needs building.
Catalog record
| CREATOR | Shujie Dong, Mengmeng Liu, Yuanyuan Zhang, Jinzi Zhang, Qin Han, Xiaohan Chen, Yibo Wu, Wai‐kit Ming |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |